Abstract:Piperlongumine (PL) has multiple anticancer effects by targeting different pathways associated with cancer. Pharmaceutical researchers have been trying to optimise the structure of PL‐derivatives to improve their drug‐likeness profiles. Drug chemistry analyses of a large number of PL‐derivatives revealed that most of them showed higher anticancer potency and drug‐ability than the native PL. Piperlongumine, or piplartine (PL), is a bioactive alkaloid isolated from Piper longum L. and a potent phytoconstituent in Indian Ayurveda and traditional Chinese medicine with a lot of therapeutic benefits. Apart from all of its biological activities, it demonstrates multimodal anticancer activity by targeting various cancer‐associated pathways and being less toxic to normal cells. According to their structure–activity relationship (SAR), the trimethylphenyl ring (cinnamoyl core) and 5,6‐dihydropyridin‐2‐(1H)‐one (piperdine core) are responsible for the potent anticancer activity. However, it has poor intrinsic properties (low aqueous solubility, poor bioavailability, etc.). As a result, pharmaceutical researchers have been trying to optimise or modify the structure of PL to improve the drug‐likeness profiles. The present review selected 26 eligible research articles on PL derivatives published between 2012 and 2023, followed by the preferred reporting items for systematic reviews and meta‐analyses (PRISMA) format. We have thoroughly summarised the anticancer potency, mode of action, SAR and drug chemistry of the proposed PL‐derivatives against different cancer cells. Overall, SAR analyses with respect to anticancer potency and drug‐ability revealed that substitution of methoxy to hydroxyl, attachment of ligustrazine and 4‐hydroxycoumarin heterocyclic rings in place of phenyl rings, and attachment of heterocyclic rings like indole at the C7‐C8 olefin position in native PL can help to improve anticancer activity, aqueous solubility, cell permeability, and bioavailability, making them potential leads. Hopefully, the large‐scale collection and critical drug‐chemistry analyses will be helpful to pharmaceutical and academic researchers in developing potential, less‐toxic and cost‐effective PL‐derivatives that can be used against different cancers.

Overview of piperlongumine analogues and their therapeutic potential

Piperlongumine and its derivatives against cancer: A recent update and future prospective

Novel Non-Trimethoxylphenyl Piperlongumine Derivatives Selectively Kill Cancer Cells.

Discovery of a Novel Piperlongumine Analogue As a Microtubule Polymerization Inhibitor with Potent Anti-Angiogenic and Anti-Metastatic Efficacy.

Synthesis and Evaluation of N -Heteroaromatic Ring-Based Analogs of Piperlongumine As Potent Anticancer Agents

Design, Synthesis and Biological Activity of Piperlongumine Derivatives As Selective Anticancer Agents.

A strategy to improve the solubility and bioavailability of the insoluble drug piperlongumine through albumin nanoparticles

Piperlongumine as anticancer agent: The story so far about killing many birds with one stone.

Synthesis, anticancer evaluation, preliminary mechanism study of novel 1, 2, 3-triazole-piperlongumine derivatives

Piperlongumine induces apoptosis and autophagy in human lung cancer cells through inhibition of PI3K/Akt/mTOR pathway

Biodegradable nanoassemblies of piperlongumine display enhanced anti-angiogenesis and anti-tumor activities.

Metabolic activation and cytochrome P450 inhibition of piperlonguminine mediated by CYP3A4

Piperlongumine inhibits head and neck squamous cell carcinoma proliferation by docking to Akt

Senolytic activity of piperlongumine analogues: Synthesis and biological evaluation

Piperlongumine Induces Apoptosis and Synergizes with Cisplatin or Paclitaxel in Human Ovarian Cancer Cells

Discovery of piperlongumine as a potential novel lead for the development of senolytic agents

Spectroscopic investigation of the anticancer alkaloid piperlongumine binding to human serum albumin from the viewpoint of drug delivery.

Piperlongumine targets NF-κB and its downstream signaling pathways to suppress tumor growth and metastatic potential in experimental colon cancer

Piperlongumine promotes autophagy via inhibition of Akt/mTOR signalling and mediates cancer cell death

Design and optimization of piperlongumine analogs as potent senolytics

Overview of Piperine: Bioactivities, Total Synthesis, Structural Modification, and Structure-Activity Relationships